Skip to content
  • Home
  • IOncology
  • Infectious Desease Frontier
  • IHepatology
  • Hematology Frontier
  • Conference topics
  • Experts Interviews
  • Informations
  • Live Broadcasting
  • Logout
MediaMedic

Connecting Medical Expertise through Media

  • Home
  • IOncology
  • Infectious Disease Frontier
  • International Hepatology
  • Hematology Frontier
  • Conference topics
  • Experts’ Interviews
  • Informations
  • Home
  • IOncology
  • Infectious Disease Frontier
  • International Hepatology
  • Hematology Frontier
  • Conference topics
  • Experts’ Interviews
  • Informations
Headlines
2026 EHA Academic Feast: Multiple Myeloma Treatment Enters a New Era of Precision Stratification—From Reshaping ASCT Status to Breaking the Deadlock in Ultra-High Risk Strategies
2026.06.25
EHA Echoes · Voices from China | Prof. Meng Lü: CAR-T vs Antibody-Based Therapy as a Bridge to Transplantation—Defining the Optimal Stratified Approach for R/R B-ALL
2026.06.25
EHA Insights | Prof. Shenmiao Yang: Toward a Cure—New Strategies in CLL Through Targeted Combination Therapy
2026.06.25
Predicting a 92% pCR: Preoperative Radiotherapy Acts as an “Immune Primer” for High-Risk TNBC in the TBCRC-053 Trial
2026.06.25
Breaking the Dilemma of Margins in Breast-Conserving Surgery: SHAVE Series Research Confirms CSM Significantly Reduces Re-excision Rates, but Long-term Survival Benefit Remains Dominated by Radiotherapy
2026.06.25
EHA Reflections | Dr. Jing Pan: Novel Nanobody-Based Dual-Epitope CD5 CAR-T Uses Speed to Redefine T-ALL Immunotherapy
2026.06.25
EHA Reflections | Professors Huilai Zhang and Junlei Jia: Decoding the Biological Landscape of Primary Breast DLBCL to Advance Precision Risk Stratification and Long-Term Disease Management
2026.06.25
EHA Reflections | Professor Fengkui Zhang: Oral Factor B Inhibitor Shows Superior Efficacy and May Redefine First-Line Treatment for PNH
2026.06.25
EHA Reflections | Professor Yizhen Li’s Plenary Session Presentation: CD5 Inhibition as a Universal Strategy to Broadly Enhance T-Cell Engager Antitumor Activity
2026.06.25
OncoFrontier AI Real-Time Subtitles On-Site Recording Cases
2026.06.25
Posted inHematology Frontier

2026 EHA Academic Feast: Multiple Myeloma Treatment Enters a New Era of Precision Stratification—From Reshaping ASCT Status to Breaking the Deadlock in Ultra-High Risk Strategies

Posted by By Mourabit Halima 2026.06.25
Continue Reading
Posted inHematology Frontier

EHA Echoes · Voices from China | Prof. Meng Lü: CAR-T vs Antibody-Based Therapy as a Bridge to Transplantation—Defining the Optimal Stratified Approach for R/R B-ALL

Posted by By Mourabit Halima 2026.06.25
Continue Reading
EHA Expert Interview | Professor Jie Jin: Zhejiang University’s Voice Resonates Internationally with GR1803 for RRMM

EHA Expert Interview | Professor Jie Jin: Zhejiang University’s Voice Resonates Internationally with GR1803 for RRMM

Posted by By Mourabit Halima 2025.03.05
The 29th European Hematology Association (EHA) Annual Meeting took place from June 13-16, 2024, in Madrid, Spain. As Europe's largest international event in the field of hematology, the meeting attracts…
Read More
Xinghai Forum: Professors Yang Zhang and Kejing Zhang Discuss CDK4/6 Inhibitors in Adjuvant Therapy for HR+ Breast Cancer

Xinghai Forum: Professors Yang Zhang and Kejing Zhang Discuss CDK4/6 Inhibitors in Adjuvant Therapy for HR+ Breast Cancer

Posted by By Mourabit Halima 2025.03.05
Xinghai Forum: Professors Yang Zhang and Kejing Zhang Discuss CDK4/6 Inhibitors in Adjuvant Therapy for HR+ Breast Cancer Editor's Note: Cyclin-dependent kinase 4/6 (CDK4/6) inhibitors have brought transformative breakthroughs to…
Read More
HNF1A Genotype & HCC Risk | Dr. Mohamed Abdel Samiee

HNF1A Genotype & HCC Risk | Dr. Mohamed Abdel Samiee

Posted by By Mourabit Halima 2025.03.05
Read More
EASL Liver Cancer Summit 2025 | Professor Abdel Ghani Badran on Ultrasound Elastography for Early HCC Detection

EASL Liver Cancer Summit 2025 | Professor Abdel Ghani Badran on Ultrasound Elastography for Early HCC Detection

Posted by By Mourabit Halima 2025.03.05
Read More
EHA 2024: Transforming Insights into Action for Better Patient Outcomes

EHA 2024: Transforming Insights into Action for Better Patient Outcomes

Posted by By Mourabit Halima 2025.03.04
As we reflect on EHA 2024, the impact of this year’s congress continues to resonate within the hematology community. The groundbreaking research, innovative treatment strategies, and expert discussions presented at…
Read More
EHA 2024: Pioneering Advances in Hematology and Innovative Therapies

EHA 2024: Pioneering Advances in Hematology and Innovative Therapies

Posted by By El Bachir MOURABIT 2025.03.04
The recent European Hematology Association (EHA) Congress highlighted crucial advancements in hematology, emphasizing the significance of cutting-edge research and its impact on clinical practices. This year's sessions provided invaluable insights…
Read More
EHA 2024: Bridging Research and Practice to Elevate Hematology Care

EHA 2024: Bridging Research and Practice to Elevate Hematology Care

Posted by By Mourabit Halima 2025.03.04
From clinical trials to real-world applications, the EHA Congress has bridged the gap between research and practice, enhancing the standard of care for hematological patients. #EHA2024 #BridgingTheGap
Read More
Exciting Moments at EHA2024 Hybrid Congress in Madrid!

Exciting Moments at EHA2024 Hybrid Congress in Madrid!

Posted by By Lisa Cui 2025.03.04
The European Hematology Association's 2024 Hybrid Congress is underway in Madrid, bringing together experts and professionals from around the world. From insightful sessions to groundbreaking research, this event is set…
Read More

 A Doctor’s Battle Against Cancer: A Story of Hope and Innovation

Posted by By Mourabit Halima 2025.03.04
An extraordinary story that shines a light on the remarkable advances in cancer treatment and the power of innovative research.Professor Richard Scolyer, co-director of the Melanoma Institute Australia, was faced…
Read More
Research Team from Beijing Chaoyang Hospital Unveils a New Mechanism Linking Double-Negative T Cells to Fatty Liver Disease Progression

Research Team from Beijing Chaoyang Hospital Unveils a New Mechanism Linking Double-Negative T Cells to Fatty Liver Disease Progression

Posted by By Mourabit Halima 2025.03.04
A research team led by Dr. Dong Zhang and Dr. Guangyong Sun from Beijing Chaoyang Hospital, Capital Medical University, in collaboration with Dr. Zhongtao Zhang from Beijing Friendship Hospital, Capital…
Read More

Posts pagination

Previous page 1 … 20
Recent Posts
  • 2026 EHA Academic Feast: Multiple Myeloma Treatment Enters a New Era of Precision Stratification—From Reshaping ASCT Status to Breaking the Deadlock in Ultra-High Risk Strategies
  • EHA Echoes · Voices from China | Prof. Meng Lü: CAR-T vs Antibody-Based Therapy as a Bridge to Transplantation—Defining the Optimal Stratified Approach for R/R B-ALL
  • EHA Insights | Prof. Shenmiao Yang: Toward a Cure—New Strategies in CLL Through Targeted Combination Therapy
  • Predicting a 92% pCR: Preoperative Radiotherapy Acts as an “Immune Primer” for High-Risk TNBC in the TBCRC-053 Trial
  • Breaking the Dilemma of Margins in Breast-Conserving Surgery: SHAVE Series Research Confirms CSM Significantly Reduces Re-excision Rates, but Long-term Survival Benefit Remains Dominated by Radiotherapy
Recent Comments
    Archives
    • June 2026
    • May 2026
    • April 2026
    • March 2026
    • February 2026
    • January 2026
    • December 2025
    • November 2025
    • October 2025
    • September 2025
    • August 2025
    • July 2025
    • June 2025
    • May 2025
    • April 2025
    • March 2025
    • February 2025
    • January 2025
    • December 2024
    • November 2024
    • October 2024
    • September 2024
    • August 2024
    • July 2024
    • June 2024
    • May 2024
    • April 2024
    • March 2024
    • February 2024
    • January 2024
    • December 2023
    • November 2023
    • October 2023
    • August 2023
    Categories
    • Artificial intelligence
    • Hematology Frontier
    • Infectious Disease Frontier
    • International Hepatology
    • IOncology
    • Live broadcasting
    • Uncategorized
    • UroStream
    Post You Might Like
    Posted inHematology Frontier
    2026 EHA Academic Feast: Multiple Myeloma Treatment Enters a New Era of Precision Stratification—From Reshaping ASCT Status to Breaking the Deadlock in Ultra-High Risk Strategies
    Posted by By Mourabit Halima 2026.06.25
    Posted inHematology Frontier
    EHA Echoes · Voices from China | Prof. Meng Lü: CAR-T vs Antibody-Based Therapy as a Bridge to Transplantation—Defining the Optimal Stratified Approach for R/R B-ALL
    Posted by By Mourabit Halima 2026.06.25
    Posted inHematology Frontier
    EHA Insights | Prof. Shenmiao Yang: Toward a Cure—New Strategies in CLL Through Targeted Combination Therapy
    Posted by By Mourabit Halima 2026.06.25
    Posted inIOncology
    Predicting a 92% pCR: Preoperative Radiotherapy Acts as an “Immune Primer” for High-Risk TNBC in the TBCRC-053 Trial
    Posted by By Mourabit Halima 2026.06.25
    • LinkedIn
    • Twitter
    • Mail
    Related Media:
    Copyright 2026 — MediaMedic. All rights reserved. Blogun WordPress Theme
    Paris, France
    Scroll to Top

    Welcome to Mediamedic 👋
    It’s nice to meet you.

    Dive into a world of trusted health insights. Subscribe for monthly updates straight to your inbox

    Privacy is part of our care. No spam, just wellness.

    🔒 Privacy policy

    Check your inbox or spam folder to confirm your subscription.

    • Facebook
    • X (Twitter)
    • LinkedIn
    • More Networks
    Share via
    Facebook
    X (Twitter)
    LinkedIn
    Mix
    Email
    Print
    Copy Link
    Copy link
    CopyCopied